New Building Blocks for the Catalytic Synthesis of Organofluorine Compounds
有机氟化合物催化合成的新结构单元
基本信息
- 批准号:RGPIN-2021-03630
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Fluorinated molecules are highly desirable targets for drug discovery and development owing to their improved potency, selectivity, and pharmacokinetic profiles when compared to non-fluorinated analogues. In the medical imaging field, 18F is a widely used radioisotope for positron emission tomography (PET) imaging due to its long half-life. Although >50% of the leading blockbuster drugs contain a fluorine atom, an analysis of fluoro-pharmaceuticals introduced in the last three decades reveals that there are few chiral organofluorine drugs currently on the market. This low representation can be attributed to the increased structural complexity of chiral molecules, combined with limited industrially friendly methods to synthesize these targets. Many of the developed asymmetric fluorination methods rely on electrophilic fluorinating reagents, which present several disadvantages on scale, such as high costs, low atom-economy, powerful oxidizing capabilities, and poor functional group tolerance. The proposed research program seeks to develop new organic reactions that harness the synthetic potential of readily accessible fluorine-containing building blocks, which are cost-effective, safer, and selective in their reactivity. Our overarching goal is to design methodologies that can transform simple starting materials into structurally and chemically diverse libraries of organofluorine compounds for biological testing. My group will explore the chemistry of two main classes of compounds, acyl fluorides and difluoroacetate derivatives, as their preparation does not require electrophilic fluorine sources and their application in catalytic asymmetric transformations remains underdeveloped. I have identified three critical areas with unmet synthetic challenges: 1) the development of complexity-building, atom-economical insertion reactions of acyl fluorides; 2) the controlled generation of transition metal difluorocarbenes under conditions amenable to asymmetric catalysis; and 3) the efficient translation of developed methodologies to 18F-radiolabeling for PET imaging applications. Leveraging tools in synthetic organic and organometallic chemistry, my group will develop novel catalysts that can facilitate the activation of these building blocks towards diverse carbon-carbon and carbon-heteroatom bond-forming reactions. Our primary focus will be on the use of nickel and boron catalysts, due to the higher natural abundance of these elements in comparison to commonly used precious metals (Pd, Pt, Rh). The central hypothesis is that rational ligand, catalyst, and reagent design will lead to the reliable prediction of reaction pathway and the discovery of new reactivity. Overall, the synthetic methodologies developed in my lab will find direct applications in drug discovery, medical imaging, and disease diagnosis, creating opportunities for interdisciplinary collaborations.
与非氟化类似物相比,氟化分子具有更高的效力、选择性和药代动力学特征,因此成为药物发现和开发非常理想的靶标。在医学成像领域,18F由于其半衰期长,是一种广泛用于正电子发射断层扫描(PET)成像的放射性同位素。尽管超过 50% 的主要重磅药物含有氟原子,但对过去三十年推出的氟药物的分析表明,目前市场上的手性有机氟药物很少。这种低代表性可归因于手性分子结构复杂性的增加,以及合成这些靶标的工业友好方法有限。许多已开发的不对称氟化方法依赖于亲电子氟化试剂,其在规模上存在一些缺点,例如成本高、原子经济性低、氧化能力强和官能团耐受性差。拟议的研究计划旨在开发新的有机反应,利用易于获得的含氟结构单元的合成潜力,这些反应具有成本效益、更安全且具有选择性。我们的首要目标是设计方法,将简单的起始材料转化为结构和化学多样化的有机氟化合物库,用于生物测试。我的小组将探索两类主要化合物的化学:酰基氟化物和二氟乙酸酯衍生物,因为它们的制备不需要亲电子氟源,并且它们在催化不对称转化中的应用仍未开发。我已经确定了三个尚未解决的合成挑战的关键领域:1)开发复杂性、原子经济的酰基氟化物插入反应; 2)在不对称催化条件下控制过渡金属二氟碳烯的生成; 3) 将已开发的方法有效转化为用于 PET 成像应用的 18F 放射性标记。利用合成有机和有机金属化学的工具,我的小组将开发新型催化剂,可以促进这些构件的活化,以实现各种碳-碳和碳-杂原子成键反应。我们的主要重点是镍和硼催化剂的使用,因为与常用的贵金属(Pd、Pt、Rh)相比,这些元素的自然丰度更高。中心假设是合理的配体、催化剂和试剂设计将导致反应途径的可靠预测和新反应性的发现。总体而言,我实验室开发的合成方法将直接应用于药物发现、医学成像和疾病诊断,为跨学科合作创造机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Le, Christine其他文献
Infantile-Onset Multisystem Neurologic, Endocrine, and Pancreatic Disease: Case and Review
- DOI:
10.1017/cjn.2019.35 - 发表时间:
2019-07-01 - 期刊:
- 影响因子:3
- 作者:
Le, Christine;Prasad, Asuri N.;Prasad, Chitra - 通讯作者:
Prasad, Chitra
Experimental and numerical investigation of 3D-Printed bone plates under four-point bending load utilizing machine learning techniques
- DOI:
10.1016/j.jmbbm.2023.105885 - 发表时间:
2023-05-14 - 期刊:
- 影响因子:3.9
- 作者:
Le, Christine;Kolasangiani, Kamal;Bougherara, Habiba - 通讯作者:
Bougherara, Habiba
Attenuation of Intestinal Inflammation in Interleukin-10-Deficient Mice Infected with Citrobacter rodentium
- DOI:
10.1128/iai.00066-14 - 发表时间:
2014-05-01 - 期刊:
- 影响因子:3.1
- 作者:
Dann, Sara M.;Le, Christine;Eckmann, Lars - 通讯作者:
Eckmann, Lars
Comparison of epicardial adipose tissue volume and coronary artery disease severity in asymptomatic adults with versus without diabetes mellitus.
患有和不患有糖尿病的无症状成人的心外膜脂肪组织体积和冠状动脉疾病严重程度的比较。
- DOI:
10.1016/j.amjcard.2014.05.057 - 发表时间:
2014-09-01 - 期刊:
- 影响因子:2.8
- 作者:
Groves, Elliott M.;Erande, Ashwini S.;Le, Christine;Salcedo, Jonathan;Hoang, Khiet C.;Kumar, Shivesh;Mohar, Dilbahar S.;Saremi, Farhood;Im, Jiye;Agrawal, Yashwant;Nadeswaran, Pradeep;Naderi, Nassim;Malik, Shaista - 通讯作者:
Malik, Shaista
Epicardial adipose tissue volume as a marker of coronary artery disease severity in patients with diabetes independent of coronary artery calcium: findings from the CTRAD study.
- DOI:
10.1016/j.diabres.2014.08.021 - 发表时间:
2014-11 - 期刊:
- 影响因子:5.1
- 作者:
Mohar, Dilbahar S.;Salcedo, Jonathan;Hoang, Khiet C.;Kumar, Shivesh;Saremi, Farhood;Erande, Ashwini S.;Naderi, Nassim;Nadeswaran, Pradeep;Le, Christine;Malik, Shaista - 通讯作者:
Malik, Shaista
Le, Christine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Le, Christine', 18)}}的其他基金
New Building Blocks for the Catalytic Synthesis of Organofluorine Compounds
有机氟化合物催化合成的新结构单元
- 批准号:
RGPIN-2021-03630 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
New Building Blocks for the Catalytic Synthesis of Organofluorine Compounds
有机氟化合物催化合成的新结构单元
- 批准号:
DGECR-2021-00409 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Launch Supplement
Biomimetic Carbocation Rearrangements Enabled by Peptide-Based Phosphoric Acid Catalysts
肽基磷酸催化剂实现仿生碳正离子重排
- 批准号:
502298-2017 - 财政年份:2018
- 资助金额:
$ 2.11万 - 项目类别:
Postdoctoral Fellowships
Biomimetic Carbocation Rearrangements Enabled by Peptide-Based Phosphoric Acid Catalysts
肽基磷酸催化剂实现仿生碳正离子重排
- 批准号:
502298-2017 - 财政年份:2017
- 资助金额:
$ 2.11万 - 项目类别:
Postdoctoral Fellowships
Biomimetic Carbocation Rearrangements Enabled by Peptide-Based Phosphoric Acid Catalysts
肽基磷酸催化剂实现仿生碳正离子重排
- 批准号:
502298-2017 - 财政年份:2016
- 资助金额:
$ 2.11万 - 项目类别:
Postdoctoral Fellowships
Designing Novel Phosphine Ligands for an Enantioselective Palladium Catalyzed Carbohalogenation
设计用于对映选择性钯催化碳卤化的新型膦配体
- 批准号:
443297-2013 - 财政年份:2015
- 资助金额:
$ 2.11万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Designing Novel Phosphine Ligands for an Enantioselective Palladium Catalyzed Carbohalogenation
设计用于对映选择性钯催化碳卤化的新型膦配体
- 批准号:
443297-2013 - 财政年份:2014
- 资助金额:
$ 2.11万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Designing Novel Phosphine Ligands for an Enantioselective Palladium Catalyzed Carbohalogenation
设计用于对映选择性钯催化碳卤化的新型膦配体
- 批准号:
443297-2013 - 财政年份:2013
- 资助金额:
$ 2.11万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
63rd Lindau Conference from June 30 to July 5, 2013
第63届林道会议 2013年6月30日至7月5日
- 批准号:
453003-2013 - 财政年份:2013
- 资助金额:
$ 2.11万 - 项目类别:
Unique Initiatives Fund
A Highly Regioselective Intermolecular Hydroacylation Strategy for the Convergent Synthesis of Polyketides
聚酮化合物趋同合成的高度区域选择性分子间氢酰化策略
- 批准号:
426374-2012 - 财政年份:2012
- 资助金额:
$ 2.11万 - 项目类别:
Postgraduate Scholarships - Master's
相似国自然基金
构件复杂背景下的实景三维古建筑物细节多层次语义提取方法研究
- 批准号:62306107
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
城市更新背景下的建筑策划智能决策与设计衔接关键技术研究
- 批准号:52378031
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自然语言驱动的建筑物室内外一体化矢量模型重建方法
- 批准号:42371457
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
光伏直驱空调系统控制与建筑被动储能协同优化机制的研究
- 批准号:52308091
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
夏热冬暖地区建筑复合表皮对城市热环境的调节机理及降温潜力研究
- 批准号:52308020
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Aliphatic polycarbonates: building blocks for new biodegradable biomaterials
脂肪族聚碳酸酯:新型可生物降解生物材料的基础材料
- 批准号:
RGPIN-2020-05598 - 财政年份:2022
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Program in the chemoenzymatic synthesis of alkaloids and medicinal agents and the development of new chiral building blocks, asymmetric protocols, and reagents
生物碱和药剂的化学酶合成以及新的手性构件、不对称方案和试剂的开发项目
- 批准号:
RGPIN-2018-03723 - 财政年份:2022
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
New Building Blocks for the Catalytic Synthesis of Organofluorine Compounds
有机氟化合物催化合成的新结构单元
- 批准号:
RGPIN-2021-03630 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Program in the chemoenzymatic synthesis of alkaloids and medicinal agents and the development of new chiral building blocks, asymmetric protocols, and reagents
生物碱和药剂的化学酶合成以及新的手性构件、不对称方案和试剂的开发项目
- 批准号:
RGPIN-2018-03723 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
New Building Blocks for the Catalytic Synthesis of Organofluorine Compounds
有机氟化合物催化合成的新结构单元
- 批准号:
DGECR-2021-00409 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Launch Supplement